PURPOSE: Palliative care's role in oncology has expanded, but its effect on aggressiveness of care at the end of life has not been characterized at the population level. METHODS: This matched retrospective cohort study examined the effect of an encounter with palliative care on health-care use at the end of life among 6,580 Medicare beneficiaries with advanced prostate, breast, lung, or colorectal cancer. We compared health-care use before and after palliative care consultation to a matched nonpalliative care cohort. RESULTS: The palliative care cohort had higher rates of health-care use in the 30 days before palliative care consultation compared with the nonpalliative cohort, with higher rates of hospitalization (risk ratio [RR], 3.33; 95% CI, 2.87 to 3.85), invasive procedures (RR, 1.75; 95% CI, 1.62 to 1.88), and chemotherapy administration (RR, 1.61; 95% CI, 1.45 to 1.78). The opposite pattern emerged in the interval from palliative care consultation through death, where the palliative care cohort had lower rates of hospitalization (RR, 0.53; 95% CI, 0.44-0.65), invasive procedures (RR, 0.52; 95% CI, 0.45 to 0.59), and chemotherapy administration (RR, 0.46; 95% CI, 0.39 to 0.53). Patients with earlier palliative care consultation in their disease course had larger absolute reductions in health-care use compared with those with palliative care consultation closer to the end of life. CONCLUSION: This population-based study found that palliative care substantially decreased health-care use among Medicare beneficiaries with advanced cancer. Given the increasing number of elderly patients with advanced cancer, this study emphasizes the importance of early integration of palliative care alongside standard oncologic care.
PURPOSE: Palliative care's role in oncology has expanded, but its effect on aggressiveness of care at the end of life has not been characterized at the population level. METHODS: This matched retrospective cohort study examined the effect of an encounter with palliative care on health-care use at the end of life among 6,580 Medicare beneficiaries with advanced prostate, breast, lung, or colorectal cancer. We compared health-care use before and after palliative care consultation to a matched nonpalliative care cohort. RESULTS: The palliative care cohort had higher rates of health-care use in the 30 days before palliative care consultation compared with the nonpalliative cohort, with higher rates of hospitalization (risk ratio [RR], 3.33; 95% CI, 2.87 to 3.85), invasive procedures (RR, 1.75; 95% CI, 1.62 to 1.88), and chemotherapy administration (RR, 1.61; 95% CI, 1.45 to 1.78). The opposite pattern emerged in the interval from palliative care consultation through death, where the palliative care cohort had lower rates of hospitalization (RR, 0.53; 95% CI, 0.44-0.65), invasive procedures (RR, 0.52; 95% CI, 0.45 to 0.59), and chemotherapy administration (RR, 0.46; 95% CI, 0.39 to 0.53). Patients with earlier palliative care consultation in their disease course had larger absolute reductions in health-care use compared with those with palliative care consultation closer to the end of life. CONCLUSION: This population-based study found that palliative care substantially decreased health-care use among Medicare beneficiaries with advanced cancer. Given the increasing number of elderly patients with advanced cancer, this study emphasizes the importance of early integration of palliative care alongside standard oncologic care.
Authors: Michael H Levy; Thomas Smith; Amy Alvarez-Perez; Anthony Back; Justin N Baker; Susan Block; Shirley N Codada; Shalini Dalal; Maria Dans; Jean S Kutner; Elizabeth Kvale; Sumathi Misra; William Mitchell; Todd M Sauer; David Spiegel; Linda Sutton; Robert M Taylor; Jennifer Temel; Roma Tickoo; Susan G Urba; Carin Van Zyl; Sharon M Weinstein; Mary Anne Bergman; Jillian L Scavone Journal: J Natl Compr Canc Netw Date: 2014-10 Impact factor: 11.908
Authors: Betty R Ferrell; Jennifer S Temel; Sarah Temin; Erin R Alesi; Tracy A Balboni; Ethan M Basch; Janice I Firn; Judith A Paice; Jeffrey M Peppercorn; Tanyanika Phillips; Ellen L Stovall; Camilla Zimmermann; Thomas J Smith Journal: J Clin Oncol Date: 2016-10-28 Impact factor: 44.544
Authors: Peter May; Melissa M Garrido; J Brian Cassel; Amy S Kelley; Diane E Meier; Charles Normand; Lee Stefanis; Thomas J Smith; R Sean Morrison Journal: Health Aff (Millwood) Date: 2016-01 Impact factor: 6.301
Authors: Glenn Gade; Ingrid Venohr; Douglas Conner; Kathleen McGrady; Jeffrey Beane; Robert H Richardson; Marilyn P Williams; Marcia Liberson; Mark Blum; Richard Della Penna Journal: J Palliat Med Date: 2008-03 Impact factor: 2.947
Authors: Elizabeth J Lilley; Katherine C Lee; John W Scott; Nicole J Krumrei; Adil H Haider; Ali Salim; Rajan Gupta; Zara Cooper Journal: J Trauma Acute Care Surg Date: 2018-11 Impact factor: 3.313
Authors: Motolani E Ogunsanya; Elizabeth A Goetzinger; Oluwatomi F Owopetu; Paulette D Chandler; Lauren E O'Connor Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-06-04 Impact factor: 4.090
Authors: Paige E Sheridan; Wendi G LeBrett; Daniel P Triplett; Eric J Roeland; Andrew R Bruggeman; Heidi N Yeung; James D Murphy Journal: Am J Hosp Palliat Care Date: 2021-01-11 Impact factor: 2.090
Authors: Jack Bevins; Nizar Bhulani; Suleyman Y Goksu; Nina N Sanford; Ang Gao; Chul Ahn; Mary E Paulk; Stephanie Terauchi; Sandi L Pruitt; Anna Tavakkoli; Ramona L Rhodes; Syed M A Kazmi; Muhammad S Beg Journal: Am J Clin Oncol Date: 2021-05-01 Impact factor: 2.787
Authors: Claire Sokas; Katherine C Lee; Daniel Sturgeon; Jocelyn Streid; Stuart R Lipsitz; Joel S Weissman; Dae H Kim; Zara Cooper Journal: J Pain Symptom Manage Date: 2020-11-16 Impact factor: 5.576